Overview

Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether eradication of Helicobacter pylori infection is effective in the improvement of platelet counts in children and adolescents with chronic ITP.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Federal University of São Paulo
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Treatments:
Clarithromycin
Furazolidone
Criteria
Inclusion Criteria:

- clinical diagnosis of chronic immune thrombocytopenic purpura

- children and adolescents up to 20 years

Exclusion Criteria:

- known hypersensitivity to any of the drugs

- recent treatment for H. pylori eradication